9-substituted minocycline compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9090541
APP PUB NO 20120283201A1
SERIAL NO

13547870

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PARATEK PHARMACEUTICALS INC75 PARK PLAZA 4TH FLOOR BOSTON MA 02116

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhatia, Beena Mansfield, US 39 1237
Messersmith, David Somerville, US 41 945
Viski, Peter Asharoken, US 27 637
Warchol, Tadeusz Northborough, US 29 552

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 28, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00